Allianz Asset Management Gmb H Bei Gene, Ltd. Transaction History

Allianz Asset Management Gmb H

$72.3 Billion
Q4 2024

A detailed history of Allianz Asset Management Gmb H transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 2,000 shares of BGNE stock, worth $453,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,000

Previous 1,000 100.0%

Holding current value

$453,420

Previous $224,000 64.73%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$174.72 - $246.04 $174,720 - $246,040	1,000 Added 100.0%	2,000 $369,000
Q3 2024 Nov 12, 2024	BUY	$143.93 - $224.51 $143,930 - $224,510	1,000 New	1,000 $224,000
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $1.94 Million - $3.04 Million	-7,817 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$249.6 - $403.14 $1.43 Million - $2.31 Million	-5,738 Reduced 42.33%	7,817 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $2.92 Million - $3.66 Million	9,985 Added 279.69%	13,555 $4.65 Million
Q1 2021 May 13, 2021	BUY	$260.64 - $382.12 $930,484 - $1.36 Million	3,570 New	3,570 $1.24 Million
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $692,660 - $984,585	-5,685 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$115.78 - $208.34 $1.64 Million - $2.95 Million	-14,150 Reduced 71.34%	5,685 $942,000
Q3 2019 Nov 13, 2019	BUY	$120.61 - $148.29 $1.87 Million - $2.29 Million	15,475 Added 354.93%	19,835 $2.42 Million
Q2 2019 Aug 08, 2019	SELL	$113.99 - $146.86 $3.09 Million - $3.98 Million	-27,072 Reduced 86.13%	4,360 $540,000
Q1 2019 May 13, 2019	SELL	$122.82 - $151.83 $3.52 Million - $4.35 Million	-28,628 Reduced 47.67%	31,432 $4.15 Million
Q4 2018 Feb 14, 2019	BUY	$107.01 - $175.15 $2.21 Million - $3.61 Million	20,625 Added 52.3%	60,060 $8.37 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $1.5 Million - $1.86 Million	9,800 Added 33.07%	39,435 $6.79 Million
Q2 2018 Aug 13, 2018	BUY	$152.5 - $216.77 $12,200 - $17,341	80 Added 0.27%	29,635 $4.56 Million
Q1 2018 May 14, 2018	SELL	$97.41 - $177.22 $440,780 - $801,920	-4,525 Reduced 13.28%	29,555 $4.97 Million
Q4 2017 Feb 13, 2018	BUY	$79.6 - $114.73 $2.71 Million - $3.91 Million	34,080	34,080 $3.33 Million

Others Institutions Holding BGNE

# of Institutions

254

Shares Held

45.1M

Call Options Held

131K

Put Options Held

95.6K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Bei Gene, Ltd. Transaction History